Siegfried Holding
Irene Wosgien (1973) has been heading Technical Operations Drug Substances since January 2021. In 2019, she joined the Siegfried Group as Multi-Site Head for several Drug Substance sites. She has many years of experience in custom manufacturing in the pharmaceutical and food industry.
Before joining Siegfried, Irene Wosgien held various senior management positions at DSM Group, most recently as Vice President Operations Human Nutrition & Health. She holds a Master's degree in chemical engineering from Eindhoven University.
Irene Wosgien is a Dutch citizen.
Siegfried Holding
1 followers
Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.